Filippo Alongi (@alongi_filippo) 's Twitter Profile
Filippo Alongi

@alongi_filippo

Chairman of Advanced Radiation Oncology, IRCCS Ospedale S.Cuore Don Calabria, Negrar-Verona & Professor at University of Brescia, Italy 🇮🇹 #radonc

ID: 1010500778908442624

calendar_today23-06-2018 12:32:14

1,1K Tweet

3,3K Followers

2,2K Following

Filippo Alongi (@alongi_filippo) 's Twitter Profile Photo

ARREST showed that SABR to all sites of polymetastatic disease is safe and feasible. Doses up to 30 Gy in 5 fractions were prescribed to a median of 16 lesions per pt with minimal acute tox. This is consider SBRT like a drug💪!

Filippo Alongi (@alongi_filippo) 's Twitter Profile Photo

Modern adaptive SBRT on prostate with MR-Linac: see the unexpected (gas bubble) and correct uncertainties in real time with gating (automatically pausing the beam delivery) and/or performing baseline shift plan adaptation. This is precision medicine!!! 🎯 Michele Rigo Elekta

Adela (@adelapoite) 's Twitter Profile Photo

Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer - Advances in Radiation Oncology advancesradonc.org/article/S2452-…

Filippo Alongi (@alongi_filippo) 's Twitter Profile Photo

Are you a young & motivated doctor interested in oncology? We want you as a resident in radiation oncology !!!! 🫵🏻 #radonc #radoncisyourchoice

Filippo Alongi (@alongi_filippo) 's Twitter Profile Photo

This national italian survey illustrates the patterns of practice and the main issues for the indication of #SBRT for spinal #oligometastases #oligocare. youngAIRO

This national italian survey illustrates the patterns of practice and the main issues for the indication of #SBRT for spinal #oligometastases  #oligocare. <a href="/airo_young/">youngAIRO</a>
Filippo Alongi (@alongi_filippo) 's Twitter Profile Photo

The present is a toxicity analysis of OligoCare cohort on the first 1′600 patients. Results documented only limited grade 3 or higher toxic events in eight cases. Treatment-related deaths were limited to two cases

ESTRO (@estro_rt) 's Twitter Profile Photo

Although some guidelines support #SBRT for oligometastatic diseases, its role in painful #bone #metastases was debated at #ESTRO24. Discover findings from trials like SC.24 and RTOG 0631 & understand SBRT's effectiveness nuances. 👉 bit.ly/4fgdaUC #radonc Luca Nicosia MD

Although some guidelines support #SBRT for oligometastatic diseases, its role in painful #bone #metastases was debated at #ESTRO24. Discover findings from trials like SC.24 and RTOG 0631 &amp; understand SBRT's effectiveness nuances. 
 👉 bit.ly/4fgdaUC #radonc <a href="/NicosiaMd/">Luca Nicosia MD</a>
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

📣📢🗣️ amplifying this - results speak for themselves! QoL outcomes are really important for patient decision making. Quite consistent with protect! #pcsm #prostatecancer #radonc GU Cast | Urology podcast!

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Great new review written by rising 🌟✨Cristian Udovicich covering essentials of ☢️PSMA PET in #ProstateCancer at IJROBP - The Red Journal - Free 50-day pre-print link here; shorturl.at/DIPcp - #pcsm #radonc

Great new review written by rising 🌟✨<a href="/cristian_udo/">Cristian Udovicich</a> covering essentials of ☢️PSMA PET in #ProstateCancer at <a href="/IJROBP/">IJROBP - The Red Journal</a> - Free 50-day pre-print link here; shorturl.at/DIPcp - #pcsm #radonc